Voyager Therapeutics, Inc.
VYGR
Revenue
15.34M
▲1.97M▲14.75%
3 Months ChangeAssets
252.28M
▼-36.03M▼-12.50%
3 Months ChangeLiabilities
56.20M
▼-12.29M▼-17.94%
3 Months ChangeFree Cash Flow
-38.55M
▼-95.18M▼-168.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001104659-26-025201
2026-02-12
Form 8-K
ID: 0001104659-26-013897
2026-01-08
Form 8-K
ID: 0001104659-26-001955
2025-11-10
Form 10-Q
ID: 0001104659-25-108846
2025-11-10
Form 8-K
ID: 0001104659-25-108841
2025-09-02
Form 8-K
ID: 0001104659-25-085977
2025-08-06
Form 10-Q
ID: 0001558370-25-010511
2025-08-06
Form 8-K
ID: 0001558370-25-010507
2025-06-05
Form 8-K
ID: 0001104659-25-056835
2025-05-06
Form 10-Q
ID: 0001558370-25-006484